Lars A. Ormandy
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
- Immune cells in cancer 2
- Immune Response and Inflammation 1
-
- vaccines and immunoinformatics approaches 1
- Co-authors
- Michael P. Manns (9 shared papers)Firouzeh Korangy (9 shared papers)Tim F. Greten (9 shared papers)Heiner Wedemeyer (3 shared papers)Bastian Hoechst (3 shared papers)Frank Lehner (2 shared papers)Tina Hillemann (1 shared paper)Christine Krüger (1 shared paper)
- Journals
- Clinical Cancer Research (1 paper)Journal of Hepatology (1 paper)Hepatology (1 paper)Journal of Immunotherapy (1 paper)OncoImmunology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Lars A. Ormandy
10 papers receiving 2.2k citations
Lars A. Ormandy's Hit Papers
Peers
Comparison fields: 5 of 70
- Immunology 1.7k
- Hepatology 310
- Oncology 1.0k
- Cancer Research 110
- Biotechnology 55
Countries citing papers authored by Lars A. Ormandy
This map shows the geographic impact of Lars A. Ormandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars A. Ormandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars A. Ormandy more than expected).
Fields of papers citing papers by Lars A. Ormandy
This network shows the impact of papers produced by Lars A. Ormandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars A. Ormandy. The network helps show where Lars A. Ormandy may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars A. Ormandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells Hit paper breakdown → | 2008 | 655 |
| 2 | Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor # Hit paper breakdown → | 2009 | 534 |
| 3 | Increased Populations of Regulatory T Cells in Peripheral Blood of Patients with Hepatocellular Carcinoma Hit paper breakdown → | 2005 | 526 |
| 4 | 2010 | 174 | |
| 5 | 2004 | 119 | |
| 6 | 2010 | 106 | |
| 7 | 2006 | 83 | |
| 8 | 2012 | 46 | |
| 9 | 2012 | 32 | |
| 10 | 2010 | 3 |
About Lars A. Ormandy
Lars A. Ormandy is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Infectious Diseases, having authored 10 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers), Immune cells in cancer (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Hepatitis B Virus Studies (1 paper), vaccines and immunoinformatics approaches (1 paper) and Immune Response and Inflammation (1 paper). The work is most often cited by research in Immunology (1.7k citations), Hepatology (310 citations), Oncology (1.0k citations), Cancer Research (110 citations) and Biotechnology (55 citations). Lars A. Ormandy has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Michael P. Manns, Firouzeh Korangy, Tim F. Greten, Heiner Wedemeyer, Bastian Hoechst, Frank Lehner, Tina Hillemann, Christine Krüger, Matthias Ballmaier and Jaba Gamrekelashvili. Their work appears in journals such as Clinical Cancer Research, Journal of Hepatology, Hepatology, Journal of Immunotherapy and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.